Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Eisenstein

Obstetrics & Gynecology Detroit, MI Medical Doctor

NPI 1164529244 CMS profile 143441

2799 W Grand Blvd, Department Of Ob/Gyn, Detroit, MI 48202

Open in the dashboard

General payments

$271,832

292 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$24,655 paid to institutions, not to them · program year 2019

Through program year 2025, David Eisenstein of Detroit, MI is reported in the CMS Open Payments database as having received $271,832 across 292 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $24,655 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,987 4
2024 General $166 3
2023 General $27,590 33
2022 General $40,173 38
2021 General $55,297 44
2020 General $28,454 28
2019 General $118,163 142

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Eisenstein
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to David Eisenstein were reported at $1,987. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year David Eisenstein Obstetrics & Gynecology median Middle half National median
2019 $118,163 $172 $62–$391 $163
2020 $28,454 $94 $36–$222 $114
2021 $55,297 $136 $42–$369 $132
2022 $40,173 $160 $50–$433 $149
2023 $27,590 $169 $56–$423 $160
2024 $166 $152 $50–$371 $164
2025 $1,987 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $105,316 115 payments
  2. Acessa Health Inc. $102,680 67 payments
  3. Acessa Health Inc. $55,694 69 payments
  4. Hologic, LLC $6,376 28 payments
  5. Applied Medical Resources Corporation $1,154 3 payments
  6. Transenterix, Inc. $161 2 payments
  7. Gynesonics, Inc. $159 2 payments
  8. Cytyc Surgical Products, LLC $144 1 payment
  9. Meditrina $74 1 payment
  10. Ethicon US, LLC $68 3 payments
  11. Other $7 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $141,692 47 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $85,425 36 payments
  3. Travel and Lodging $39,748 116 payments
  4. Food and Beverage $4,953 91 payments
  5. Education $14 2 payments
Products named General payments · program years 2019–2025
  1. ACESSA PROVU SYSTEM Surgical $66,050 67 payments
  2. Orilissa Endocrinology $63,747 73 payments
  3. Acessa $55,694 69 payments
  4. ACESSA PROVU SYSTEM Surgical $40,191 24 payments
  5. ORILISSA Womens Health $22,502 20 payments
  6. ORIAHNN $10,709 9 payments
  7. GelPOINT V-Path $1,154 3 payments
  8. Senhance Surgical Robotics System $161 2 payments
  9. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM $130 1 payment
  10. FLUENT FLUID MANAGEMENT SYSTEM $130 1 payment
  11. Other $185 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

44

Median for Obstetrics & Gynecology: 65

Drug cost

$2,360

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

0%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 31 $2,319
Diazepam Generic 13 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$7,099

Medicare's payments for the services billed

Medicare patients

26

Average age 67

Services billed

61

26 women, 0 men among their patients

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

292 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record